Used as a key intermediate in the synthesis of kinase inhibitors for cancer treatment. Commonly employed in pharmaceutical research to develop targeted therapies, especially in oncology. Its structure allows for selective binding to ATP sites in protein kinases, making it valuable in designing drugs that modulate signaling pathways involved in tumor growth. Also utilized in the development of antiviral agents due to its ability to mimic purine bases in nucleic acid analogs.